Show simple item record

dc.creatorObradović, Milan M.
dc.creatorStanimirović, Julijana
dc.creatorPanić, Anastasija
dc.creatorBogdanović, Nikola
dc.creatorSudar, Emina
dc.creatorCenic-Milosevic, Desanka
dc.creatorIsenović, Esma R.
dc.date.accessioned2018-03-01T17:38:08Z
dc.date.available2018-03-01T17:38:08Z
dc.date.issued2017
dc.identifier.issn1381-6128 (print)
dc.identifier.issn1873-4286 (electronic)
dc.identifier.urihttp://vinar.vin.bg.ac.rs/handle/123456789/1581
dc.description.abstractBackground: The sodium/potassium- adenosine- triphosphatase (Na+/K+-ATPase) is an important mediator in vasculature tone and contractility, and its abnormal regulation has been implicated in many diseases such as obesity, insulin resistance, diabetes, and hypertension. Decreased Na+/K+-ATPase abundance and its altered isoform expression induce cardiomyocytes death and cardiac dysfunction, possibly leading to the development of myocardial dilation and heart failure. Therefore, the regulation of Na+/K+-ATPase activity/expression could be important in treatment and possible prevention of cardio-metabolic diseases. A number of hormones and environmental factors regulate the function of Na+/K+-ATPase in response to changing cellular requirements. Estradiol and insulin like growth factor-1 (IGF-1) are among potent hormones that positively regulate Na+/K+-ATPase activity or de novo synthesis of alpha -and beta -subunits. Both estradiol and IGF-1 have a huge therapeutic potential in treatment of vasculopathy in cardio-metabolic diseases. Methods: We searched the MEDLINE and PUBMED databases for all English and non-English articles with an English abstract from April 1978 to May 2016. The main data search terms were: Na+/K+-ATPase; estradiol and Na+/K+-ATPase; estradiol, Na+/K+-ATPase and CVS; estradiol, Na+/K+-ATPase and CVD; estradiol, Na+/K+-ATPase and obesity; estradiol, Na+/K+-ATPase and diabetes; estradiol, Na+/K+-ATPase and hypertension; IGF-1; IGF-1 and Na+/K+-ATPase; IGF-1, Na+/K+-ATPase and CVS; IGF-1, Na+/K+-ATPase and CVD; IGF-1, Na+/K+-ATPase and obesity; IGF-1, Na+/K+-ATPase and diabetes; IGF-1, Na+/K+-ATPase and hypertension. Results: The present review discusses the latest data from animal and human studies which focus on the effects of estradiol and IGF-1 on Na+/K+-ATPase regulation in physiological and pathophysiological conditions in cardiovascular system. Conclusion: Understanding the molecular mechanisms of estradiol and IGF-1 action on Na+/K+-ATPase in humans, may help resolving outstanding issues and developing new strategies for the protection and treatment of cardiovascular diseases.en
dc.relationinfo:eu-repo/grantAgreement/MESTD/Basic Research (BR or ON)/173033/RS//
dc.rightsrestrictedAccessen
dc.sourceCurrent Pharmaceutical Designen
dc.subjectSodium potassium adenosine-triphosphataseen
dc.subjectestradiolen
dc.subjectinsulin like growth factor-1en
dc.subjectcardio-metabolic diseasesen
dc.titleRegulation of Na+/K+-ATPase by Estradiol and IGF-1 in Cardio-Metabolic Diseasesen
dc.typereviewen
dcterms.abstractПаниц, Aнастасија; Обрадовић Милан; Цениц-Милосевиц, Десанка; Станимировић Јулијана; Богдановиц, Никола; Судар Емина; Исеновић Есма;
dc.citation.volume23
dc.citation.issue10
dc.citation.spage1551
dc.citation.epage1561
dc.identifier.wos000401430400016
dc.identifier.doi10.2174/1381612823666170203113455
dc.identifier.pmid28164755
dc.identifier.scopus2-s2.0-85019624351


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record